Miguel Vieira Martins, Paola De Lorenzo, Rishi S. Kotecha, Andishe Attarbaschi, Gabriele Escherich, Karsten Nysom, Jan Stary, Alina Ferster, Benoit Brethon, Franco Locatelli, Martin Schrappe, Peggy E. Scholte-van Houtem, Maria G. Valsecchi, Alwin D.R. Huitema, Rob Pieters, Inge M. van der Sluis. "Sustained Benefit of Blinatumomab in Infants With
                    <i>KMT2A</i>
                    -Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics." Journal of Clinical Oncology, 2026. doi:10.1200/jco-25-01806